A study of tracheobronchial basal cells reveals a mechanism by which lung squamous cell carcinoma is almost universally initiated by exploitation of a stem cell injury response involving SOX2 and PI3K. The gene discussed is SOX2; the disease is squamous cell lung carcinoma.